Physician profile
Christa Jackson
NPI 1356719264
$1,470.79
in general payments reported to CMS, 2019-2025
21 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $682 · 2022: $377 · 2023: $96.86 · 2024: $118 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $259.41 | 2021-2023 | |
| Aspira Women'S Health INC | $241.52 | 2021-2022 | |
| Galderma Laboratories, L.P. | $180.25 | 2022-2025 | Dysport |
| Merz North America, INC. | $149.51 | 2025 | |
| Abbott Laboratories | $83.83 | 2023-2024 | Freestyle Libre 3 |
| Organon LLC | $68.76 | 2021-2023 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $65.21 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $63.36 | 2021-2022 | |
| Scynexis, INC. | $52.24 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $44.75 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $40.90 | 2021 | |
| Shield Therapeutics INC | $33.87 | 2024 | |
| Avion Pharmaceuticals | $32.06 | 2021 | |
| Exeltis, USA INC. | $29.67 | 2021 | |
| Therapeuticsmd, INC. | $28.25 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $26.45 | 2022-2023 | |
| Astellas Pharma US INC | $14.91 | 2024 | Veozah |
| Revance Therapeutics, INC. | $14.62 | 2024 | Daxxify |
| Smith+Nephew, INC. | $14.44 | 2022 | |
| Evofem Biosciences, INC. | $13.43 | 2021 | |
| Agile Therapeutics, INC. | $13.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christa Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.